Compare StocksIR vs PFE

Ingersoll Rand Inc. (IR) vs Pfizer, Inc. (PFE): Which Is the Better Buy in 2026?

As of 2026-08-03, IR is undervalued at $83, with a DCF intrinsic value of $18513221898 and a margin of safety of 100%. PFE is undervalued at $25, with an intrinsic value of $127985960274 and a margin of safety of 100%. Of the two, PFE has the wider margin of safety.

IR
Ingersoll Rand Inc.
$83.38
VS
PFE
Pfizer, Inc.
$25.01

Rewards

IR
  • Free cash flow has grown at a 16.8% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • Trailing P/E of 34.5x is 20% below the historical average of 43.3x — potentially undervalued relative to its own history.
  • PEG ratio of 0.80 suggests the stock is undervalued relative to its growth rate — paying less than 1x for each unit of earnings growth.
PFE
  • Gross margin of 74.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Trailing P/E of 19.1x is 37% below the historical average of 30.4x — potentially undervalued relative to its own history.

Risks

IR
  • Each dollar of retained earnings has produced only $0.05 of earning power — shareholders may have been better served by dividends.
  • Altman Z-Score of 1.07 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
  • 14 insider sales with no purchases over the past 12 months — a persistent pattern of insider selling.
PFE
  • ROIC has declined by 15.9 percentage points over the past 4 years, which may signal competitive erosion.
  • PEG ratio of 2.94 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Altman Z-Score of 1.38 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.

Key Valuation Metrics

Learn more →
IR
PFE
Valuation
$1.11B
Free Cash Flow
$12.38B
N/A
FCF Yield
N/A
34.45
Trailing P/E
19.09
21.54
Forward P/E
8.85
Quality & Moat
6.99%
ROIC
10.19%
9.47%
ROE
8.31%
42.82%
Gross Margin
74.80%
0.80
PEG Ratio
2.94
Balance Sheet Safety
0.36
Net Debt / Equity
0.57
N/A
Interest Coverage
N/A
1.85
Net Debt / EBITDA
2.03
0.10%
Dividend Yield
6.88%
IR: 4Ties: 1PFE: 6
IRPFE

Historical Fundamentals

Learn more →
IR

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

PFE

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
IR
$0.00
created per $1 retained over 3 years
Value Destroyer
Σ Retained
$2.10B
Δ Market Cap
+$26.97
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
PFE
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-10.61B
Δ Market Cap
$-26.34
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
IR
100.0% Margin of Safety
Price is 100.0% below estimated fair value
Current Price: $83.38
Fair Value: $18513221897.85
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
PFE
100.0% Margin of Safety
Price is 100.0% below estimated fair value
Current Price: $25.01
Fair Value: $127985960274.09
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
IR

What growth rate is the market pricing in at $83?

-16.1%
Market-Implied Owner Earnings Growth
Standard FCF implies -18.7%

The market implies -16.1% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding -18.7%, reflecting heavy growth investment expected to generate future returns.

PFE

What growth rate is the market pricing in at $25?

-14.2%
Market-Implied Owner Earnings Growth
Standard FCF implies -15.0%

The market implies -14.2% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding -15.0%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
IR
59/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with reinvestment efficiency as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
PFE
35/100
No Moat
70+ Wide · 40-69 Narrow · <40 None

No durable moat detected, though reinvestment efficiency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
IR
-2.55
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
PFE
-2.53
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
IR
Insiders 0.2%Institutions 107.3%
No. of Institutional Holders1,260
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
PFE
Insiders 0.1%Institutions 69.5%Retail & Other 30.4%
No. of Institutional Holders3,661
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
IR
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
PFE
0
Buys (3M)
0
Buys (12M)
BLAYLOCK RONALD E
Director
$499,072
@ $25.65 · 2025-02-13
GOTTLIEB SCOTT
Director
$28,240
@ $28.24 · 2024-10-30
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
IR
0
Sells (3M)
14
Sells (12M)
Total value (12M): $59.54M
REYNAL VICENTE
Chief Executive Officer
$2.68M
@ $88.00 · 2026-04-13
REYNAL VICENTE
Chief Executive Officer
$11.11M
@ $94.11 · 2026-03-02
KINI VIKRAM
Chief Financial Officer
$2.74M
@ $96.50 · 2026-02-20
HUMPHREY JOHN R.
Director
$412,370
@ $95.90 · 2026-02-19
REYNAL VICENTE
Chief Executive Officer
$90,000
@ $100.00 · 2026-02-18
SCHESKE MICHAEL J
Officer
$1.87M
@ $97.67 · 2026-02-17
KEENE KATHLEEN M
Officer
$1.19M
@ $99.46 · 2026-02-17
SCHIESL ANDREW R
General Counsel
$1.76M
@ $98.00 · 2026-02-17
HEPDING ELIZABETH MELOY
Officer
$1.77M
@ $97.11 · 2026-02-17
REYNAL VICENTE
Chief Executive Officer
$9.17M
@ $99.25 · 2026-02-17
REYNAL VICENTE
Chief Executive Officer
$44,000
@ $100.00 · 2026-02-11
REYNAL VICENTE
Chief Executive Officer
$9.75M
@ $97.54 · 2026-02-04
REYNAL VICENTE
Chief Executive Officer
$16.83M
@ $88.12 · 2026-01-16
SCHESKE MICHAEL J
Officer
$119,086
@ $80.63 · 2025-12-01
REYNAL VICENTE
Chief Executive Officer
$3.21M
@ $83.03 · 2025-05-20
HEPDING ELIZABETH MELOY
Officer
$293,230
@ $83.78 · 2025-05-14
SCHIESL ANDREW R
General Counsel
$976,316
@ $84.90 · 2025-05-13
SCHIESL ANDREW R
General Counsel
$1.15M
@ $87.05 · 2025-02-18
SCHIESL ANDREW R
General Counsel
$2.30M
@ $95.08 · 2024-11-05
SCHESKE MICHAEL J
Officer
$246,621
@ $97.44 · 2024-11-05
KEENE KATHLEEN M
Officer
$420,673
@ $90.00 · 2024-08-28
HEPDING ELIZABETH MELOY
Officer
$685,650
@ $91.42 · 2024-08-21
REYNAL VICENTE
Chief Executive Officer
$4.63M
@ $92.51 · 2024-08-15
SCHIESL ANDREW R
General Counsel
$2.16M
@ $90.05 · 2024-08-09
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
PFE
1
Sells (3M)
1
Sells (12M)
Total value (12M): $51,400
DAMICO JENNIFER B.
Officer
$51,400
@ $25.70 · 2026-06-09
DAMICO JENNIFER B.
Officer
$64,825
@ $25.93 · 2025-03-04
DAMICO JENNIFER B.
Officer
$147,714
@ $28.66 · 2024-08-13
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
IR
FearGreed
😐Neutral(52/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
PFE
FearGreed
😐Neutral(52/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
IR
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (52)
PFE
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (52)
View IR Full AnalysisView PFE Full Analysis

Frequently Asked Questions: IR vs PFE

Is Ingersoll Rand Inc. or Pfizer, Inc. more undervalued in 2026?

Based on our discounted cash flow model, PFE trades at a 100.0% margin of safety (intrinsic value $127985960274 vs. price $25), compared to IR's 100.0% margin of safety (intrinsic $18513221898 vs. $83).

Which stock has a wider economic moat, Ingersoll Rand Inc. or Pfizer, Inc.?

IR scores 59/100 (Narrow moat), while PFE scores 35/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Ingersoll Rand Inc. in financial distress?

IR's Altman Z-Score of 1.1 places it in the Distress zone, signaling elevated bankruptcy risk. PFE scores 1.4 (Distress zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, Ingersoll Rand Inc. or Pfizer, Inc.?

PFE earns 10.2% ROIC versus IR's 7.0%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Ingersoll Rand Inc.'s or Pfizer, Inc.'s?

IR's dividend earns a safety score of 85/100 (Very Safe), compared to PFE's 24/100 (Unsafe). IR has raised its dividend for 0 consecutive years.